The Food and Drug Administration approved a nasal spray intended to treat severe allergic reactions on Friday, expanding options beyond needle-based treatments like the EpiPen. The nasal spray ...

A newly approved nasal spray for serious allergic reactions will serve as a critical alternative to EpiPens and other auto-injectors, helping to treat such reactions quicker in people who are ...

The Food and Drug Administration approved a new nasal spray Friday as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray, which is made by ARS ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...

Soon people will be able to subdue a severe allergic reaction with a nasal spray instead of an injection. The hormone epinephrine is the go-to therapy for anaphylaxis, a potentially life ...

The Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions, the agency said on Friday.

On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray influenza (flu) vaccine. The vaccine, FluMist, can be administered by either the ...

The agency on Friday gave the green light for people who have been screened to give themselves the FluMist nasal spray, which can be ordered directly from an online pharmacy, skipping the need to ...